EpigeneticTx Named to Forbes Asia's '100 To Watch' List for 2024 Amid IPO Filing

The recently announced fourth "2024 Forbes Asia-Pacific 100 Most Promising Companies" list aims to showcase small and start-up companies in the Asia-Pacific region that have garnered significant investor attention. These 100 companies have demonstrated strong innovation capabilities, with business areas covering a wide range, from AI navigation systems for space exploration to cutting-edge cell therapies and advanced medical diagnostic technologies. The list includes companies from 16 countries and regions, spanning 10 industries including enterprise technology and robotics, finance, manufacturing, and energy. India tops the list with 20 companies, followed by Singapore (15), China (10), Japan (9), and Indonesia (8). Epigenic Therapeutics, Inc. has successfully been selected for the "2024 Forbes Asia-Pacific 100 Most Promising Companies" list due to its outstanding innovation capabilities and leading technology.

Epigenic stated that in the future, it will continue to conduct in-depth research in the life sciences field, continuously enhance its innovation capabilities, and is committed to providing safer and more effective treatment options for patients with chronic diseases. The company aims to maintain a leading position in the field of epigenetic therapies, offering more treatment choices to patients worldwide and promoting the widespread application of gene regulation therapies.